GlassScriptPhysician profile
Bruce H Kole
NPI 1437195013
$886.45
in general payments reported to CMS, 2019-2025
12 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.67 · 2021: $36.81 · 2022: $169 · 2023: $177 · 2024: $110 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $350.67 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $174.58 | 2025 | Wainua |
| Azurity Pharmaceuticals, INC. | $96.09 | 2024-2025 | Horizant |
| Abbvie INC. | $71.58 | 2024-2025 | |
| Abiomed | $30.91 | 2025 | |
| Cycle Pharmaceuticals INC | $30.45 | 2025 | Bafiertam, Tascenso Odt |
| Eisai INC. | $30.42 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $28.70 | 2025 | Assure Wcd |
| Ucb, INC. | $23.80 | 2025 | Rystiggo |
| Edwards Lifesciences Corporation | $16.82 | 2023 | Sapien 3 Ultra Resilia |
| Emd Serono, INC. | $16.67 | 2019 | |
| Pfizer INC. | $15.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Kole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.